Clinical Trial

Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity

Study acronym: GynLight
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-12-06; most recent amendment 2023-09-28.
Status change: Not Yet Recruiting → Recruiting 2022-09-16
Trial Details
NCT Number NCT05165056
Lead Sponsor Jessa Hospital
Collaborators: Ziekenhuis Oost-Limburg, Hasselt University
Conditions Radiotherapy Side Effect, Vaginal Abnormality
Enrollment 62 participants
Start Date 2022-08-24
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2023-09-29